Diagnostic performance of [<sup>18</sup>F]-FDG PET/MR in evaluating colorectal cancer: a systematic review and meta-analysis.

Seyed Ali MirshahvaladRicarda HinzpeterAndres KohanReut AnconinaRoshini KulanthaiveluClaudia OrtegaUr MetserPatrick Veit-Haibach

Published in: European journal of nuclear medicine and molecular imaging (2022)

This meta-analysis showed an overall high diagnostic performance for [<sup>18</sup>F]-FDG PET/MR in detecting CRC lesions/metastases. Thus, this modality can play a significant role in several clinical scenarios in CRC staging and restaging. Specifically, one of the main strengths of this modality is ruling out the existence of CRC lesions/metastases. Finally, the overall diagnostic performance was not found to be affected in the post-treatment setting.

Keyphrases

pet ct
positron emission tomography
pet imaging
systematic review
computed tomography
contrast enhanced
magnetic resonance
climate change
lymph node
combination therapy
case control
replacement therapy